| scholarly article | Q13442814 |
| P50 | author | Honglin Tian | Q64355160 |
| P2093 | author name string | Tianyuan Cui | |
| Qi Wan | |||
| Mei Zheng | |||
| Dong-Sheng Fan | |||
| Mingxia Liao | |||
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| The glutamate receptor ion channels | Q28137916 | ||
| TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis | Q28270779 | ||
| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis | Q28335672 | ||
| Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs | Q28564702 | ||
| Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. | Q29568322 | ||
| TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q29615597 | ||
| Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways | Q29619779 | ||
| Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6 | Q30492839 | ||
| TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration | Q30493749 | ||
| Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis | Q30494776 | ||
| Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members | Q31836858 | ||
| Chronic mitochondrial inhibition induces glutamate-mediated corticomotoneuron death in an organotypic culture model | Q31848460 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis | Q33649745 | ||
| TDP-43 is a developmentally regulated protein essential for early embryonic development | Q33673895 | ||
| The changing landscape of ischaemic brain injury mechanisms. | Q33678157 | ||
| Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). | Q33799562 | ||
| Activation of NR2A receptors induces ischemic tolerance through CREB signaling | Q34171285 | ||
| Bisperoxovanadium compounds are potent PTEN inhibitors. | Q34321332 | ||
| Neuroprotective agents for clinical trials in ALS: a systematic assessment | Q34568968 | ||
| Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation | Q35172825 | ||
| Glutamate signaling to Ras-MAPK in striatal neurons: mechanisms for inducible gene expression and plasticity | Q35700587 | ||
| Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury | Q35723626 | ||
| TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions | Q35928153 | ||
| Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q36734898 | ||
| Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation | Q36741538 | ||
| Phosphatase PTEN in neuronal injury and brain disorders | Q36980931 | ||
| Glutamate receptor plasticity and activity-regulated cytoskeletal associated protein regulation in the phrenic motor nucleus may mediate spontaneous recovery of the hemidiaphragm following chronic cervical spinal cord injury | Q36990537 | ||
| The nuclear affairs of PTEN. | Q37063858 | ||
| Calcium dysregulation in amyotrophic lateral sclerosis | Q37684077 | ||
| TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases | Q39836728 | ||
| Structural determinants of the cellular localization and shuttling of TDP-43. | Q39924105 | ||
| Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration | Q40922137 | ||
| Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin | Q41094368 | ||
| Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study | Q43103365 | ||
| In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses | Q43266988 | ||
| Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury | Q43271378 | ||
| Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. | Q45919147 | ||
| Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance | Q46440028 | ||
| Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor | Q46527954 | ||
| Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. | Q46817719 | ||
| Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition. | Q46852738 | ||
| Differential vulnerability of autonomic and somatic motor neurons to N-methyl-D-aspartate-induced excitotoxicity | Q47616716 | ||
| Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. | Q47856562 | ||
| Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in arginine-depleted neurons | Q48137669 | ||
| Brain glutamate deficiency in amyotrophic lateral sclerosis | Q48180224 | ||
| Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. | Q48183466 | ||
| TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. | Q48199429 | ||
| NMDA-dependent superoxide production and neurotoxicity | Q48234286 | ||
| NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo | Q48241774 | ||
| Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. | Q48535231 | ||
| Modulation of GABAA receptor function by tyrosine phosphorylation of beta subunits | Q48679503 | ||
| Abnormal glutamate metabolism in amyotrophic lateral sclerosis. | Q51628220 | ||
| TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. | Q51920306 | ||
| Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. | Q53299106 | ||
| Glutamate transport blockade has a differential effect on AMPA and NMDA receptor-mediated synaptic transmission in the developing barrel cortex | Q57752898 | ||
| A clinical trial of dextromethorphan in amyotrophic lateral sclerosis | Q73598803 | ||
| Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro | Q79236027 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | Pt 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1556-1567 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Journal of Cell Science | Q1524177 |
| P1476 | title | Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN. | |
| P478 | volume | 125 |
| Q35194634 | A network of RNA and protein interactions in Fronto Temporal Dementia |
| Q38996097 | Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection |
| Q46082313 | Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries |
| Q36529884 | Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death. |
| Q55437977 | ERK 1/2 Activation Mediates the Neuroprotective Effect of BpV(pic) in Focal Cerebral Ischemia-Reperfusion Injury. |
| Q38100646 | GluN2A versus GluN2B: twins, but quite different |
| Q42760842 | Glycine confers neuroprotection through microRNA-301a/PTEN signaling |
| Q35274780 | Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia |
| Q90707597 | MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury |
| Q92187641 | PTEN Inhibition Protects Against Experimental Intracerebral Hemorrhage-Induced Brain Injury Through PTEN/E2F1/β-Catenin Pathway |
| Q38690404 | Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis |
| Q64084703 | Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors |
| Q47266756 | Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus |
| Q37216891 | RNA-mediated toxicity in neurodegenerative disease |
| Q38197689 | Targeting TDP-43 in neurodegenerative diseases |
| Q38707263 | The Functional and Molecular Properties, Physiological Functions, and Pathophysiological Roles of GluN2A in the Central Nervous System |
| Q39094792 | The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter |
| Q92236554 | The neuroprotective effect of bisperoxovandium (pyridin-2-squaramide) in intracerebral hemorrhage |
Search more.